Business & Industry

According to medical device firm Cook Medical, the costs associated with the tariff policy of Donald Trump will, wherever possible, get passed onto the US customers. This happens to be as per the directors at one of the largest employers...

Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central...

The Chinese pharmaceutical firms are increasingly looking out for the local reagent suppliers so as to cut the costs as well as delivery times. Growing import tariffs because of the US-China trade war, as well as concerns with regard...

The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU. The declaration made by Trump that the drug exports of Europe will be hit with certain...

Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel the United States to the forefront of global AI leadership. Within its three pillars—innovation, infrastructure,...

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that are participating in the 340B drugs discount program. The pilot happens to depart from the...

President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been posted by Trump on social media Say name-brand drug prices are almost three times...